Cargando…

Japanese encephalitis vaccination in the Philippines: A cost-effectiveness analysis comparing alternative delivery strategies

INTRODUCTION: Japanese encephalitis (JE) is a mosquito-borne viral infection of the brain that can cause permanent brain damage and death. In the Philippines, efforts are underway to deliver a live attenuated JE vaccine (CD-JEV) to children under five years of age (YOA), who are disproportionately i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vodicka, Elisabeth, Zimmermann, Marita, Lopez, Anna Lena, Silva, Maria Wilda, Gorgolon, Leonita, Kohei, Toda, Mooney, Jessica, Muhib, Farzana, Pecenka, Clint, Marfin, Anthony A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068699/ https://www.ncbi.nlm.nih.gov/pubmed/32085954 http://dx.doi.org/10.1016/j.vaccine.2020.02.018

Ejemplares similares

Risk-based Vaccines and the Need for Risk-based Subnational Vaccination Strategies for Introduction
por: Muhib, Farzana B, et al.
Publicado: (2020)

Cost-effectiveness of rotavirus vaccination in the Philippines: A modeling study
por: Villanueva-Uy, Maria Esterlita T., et al.
Publicado: (2021)

Epidemiology of Japanese Encephalitis in the Philippines: A Systematic Review
por: Lopez, Anna Lena, et al.
Publicado: (2015)

Cost of Acute and Sequelae Care for Japanese Encephalitis Patients, Bangladesh, 2011–2021
por: Sultana, Rebeca, et al.
Publicado: (2023)

Potential impact and cost-effectiveness of Shigella vaccination in 102 low-income and middle-income countries in children aged 5 years or younger: a modelling study
por: Anderson, John D, et al.
Publicado: (2023)

Japanese encephalitis virus genotype III from mosquitoes in Tarlac, Philippines
por: Aure, Wilfredo E., et al.
Publicado: (2022)

Pneumococcal conjugate vaccination in The Gambia: health impact, cost effectiveness and budget implications
por: Pecenka, Clint, et al.
Publicado: (2021)

Estimating the cost of illness of acute Japanese encephalitis and sequelae care in Vietnam and Laos: A cross-sectional study
por: Nguyen, An Le Thanh, et al.
Publicado: (2023)

Projecting the long-term economic benefits of reducing Shigella-attributable linear growth faltering with a potential vaccine: a modelling study
por: Puett, Chloe, et al.
Publicado: (2023)

Prospects for rotavirus vaccine introduction in the Philippines: Bridging the available evidence into immunization policy
por: Lopez, Anna Lena, et al.
Publicado: (2019)

Expanding japanese encephalitis vaccination to selected endemic indonesia provinces: A cost-effectiveness analysis
por: Kosen, Soewarta, et al.
Publicado: (2022)

Japanese Encephalitis Virus as Cause of Acute Encephalitis, Bhutan
por: Wangchuk, Sonam, et al.
Publicado: (2020)

Estimating the Economic Impact of Respiratory Syncytial Virus and Other Acute Respiratory Infections Among Infants Receiving Care at a Referral Hospital in Malawi
por: Baral, Ranju, et al.
Publicado: (2020)

Household Costs of Diarrhea by Etiology in 7 Countries, The Global Enterics Mulitcenter Study (GEMS)
por: Zimmermann, Marita, et al.
Publicado: (2019)

The potential cost-effectiveness of HPV vaccination among girls in Mongolia
por: Luvsan, Munkh-Erdene, et al.
Publicado: (2022)

Cost of introducing and delivering RTS,S/AS01 malaria vaccine within the malaria vaccine implementation program
por: Baral, Ranju, et al.
Publicado: (2023)

Potential health impact and cost-effectiveness of bivalent human papillomavirus (HPV) vaccination in Afghanistan
por: Anwari, Palwasha, et al.
Publicado: (2020)

Immunogenicity and safety of concurrent or sequential administration of live, attenuated SA 14-14-2 Japanese encephalitis vaccine (CD-JEV) and measles-mumps-rubella vaccine in infants 9–12 months of age in the Philippines: A non-inferiority Phase 4 randomized clinical trial
por: Capeding, Maria Rosario, et al.
Publicado: (2020)

Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance
por: Hills, Susan, et al.
Publicado: (2009)

Impact and cost-effectiveness of rotavirus vaccination in Niger: a modelling study evaluating alternative rotavirus vaccines
por: Debellut, Frédéric, et al.
Publicado: (2022)

Cost of childhood RSV management and cost-effectiveness of RSV interventions: a systematic review from a low- and middle-income country perspective
por: Wittenauer, Rachel, et al.
Publicado: (2023)

Japanese Encephalitis, Singapore
por: Koh, Yin-Ling, et al.
Publicado: (2006)

Japanese Encephalitis Vaccines
por: Satchidanandam, Vijaya
Publicado: (2020)

Japanese B Encephalitis
por: Mehta, Anita, et al.
Publicado: (2021)

Investigation of Japanese encephalitis virus as a cause of acute encephalitis in southern Pakistan, April 2015–January 2018
por: Fatima, Tazeen, et al.
Publicado: (2020)

Japanese Encephalitis Surveillance and Immunization — Asia and Western Pacific Regions, 2016
por: Heffelfinger, James D., et al.
Publicado: (2017)

Persistence of IgM Antibodies after Vaccination with Live Attenuated Japanese Encephalitis Vaccine
por: Hills, Susan L., et al.
Publicado: (2021)

Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries
por: Baral, Ranju, et al.
Publicado: (2021)

The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control
por: Vannice, Kirsten S., et al.
Publicado: (2021)

Correction: Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries
por: Baral, Ranju, et al.
Publicado: (2021)

Japanese encephalitis acquired in Australia.
Publicado: (1995)

Japanese Encephalitis, Tibet, China
por: Li, Yi-Xing, et al.
Publicado: (2011)

Japanese encephalitis: The virus and vaccines
por: Yun, Sang-Im, et al.
Publicado: (2014)

Recent advances in Japanese encephalitis
por: Basu, Anirban, et al.
Publicado: (2017)

Regulation of inflammation in Japanese encephalitis
por: Lannes, Nils, et al.
Publicado: (2017)

Safety of Japanese encephalitis vaccines
por: Hu, Ya-Li, et al.
Publicado: (2021)

Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV–Primed Children in the Philippines
por: Capeding, Maria Rosario, et al.
Publicado: (2018)

Heterogeneity in potential impact and cost-effectiveness of ETEC and Shigella vaccination in four sub-Saharan African countries
por: Anderson, John D., et al.
Publicado: (2019)

The changing epidemiology of Japanese encephalitis and New data: the implications for New recommendations for Japanese encephalitis vaccine
por: Connor, Bradley, et al.
Publicado: (2017)

Changes in age-specific seroprevalence of Japanese encephalitis virus and impact of Japanese encephalitis vaccine in Korea
por: Kwak, Byung Ok, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a41k1gt5nkmktsm4f6gin643i6